This study focuses on pregnant women with chronic hypertension, a condition where blood pressure remains consistently high. The research examines how acetylsalicylic acid (also known as aspirin) affects pregnancy-related complications including pre-eclampsia (a serious condition causing high blood pressure during pregnancy), fetal growth restriction (when a baby doesn’t grow properly in the womb), and other pregnancy-related blood pressure problems.
The study compares the effects of taking 150 mg of acetylsalicylic acid daily with a placebo to prevent serious complications that could affect both mother and baby. These complications include pre-eclampsia, separation of the placenta from the womb, reduced baby growth, early delivery, and other serious health issues for both mother and baby.
Participants in this study will receive either acetylsalicylic acid in the form of gastro-resistant tablets (tablets that dissolve in the intestine rather than the stomach) or identical-looking placebo tablets. The treatment continues for 6 months during pregnancy. The study is designed so that neither the pregnant women nor their healthcare providers know which treatment they are receiving during the study period.



France